Divergent immuno-landscapes: comparing the tumor microenvironment of Indian and Western HNSCC patients. [PDF]
Kumar Rai P, Choudhary B.
europepmc +1 more source
Anlotinib as Third-Line or Later Therapy in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Real-World Efficacy and Safety Outcomes. [PDF]
Li Y, Li S, Li Y, Pan Z.
europepmc +1 more source
RAPTOR Silencing Inhibits Head and Neck Squamous Cell Carcinoma Progression via Regulation of S100A8/A9 and Urokinase Plasminogen Activator. [PDF]
Fu Z +7 more
europepmc +1 more source
Advancements in Image-Based Artificial Intelligence in the Diagnosis and Treatment of Head and Neck Squamous Cell Carcinoma: A Narrative Review. [PDF]
Wu B, Gu J, Chen T.
europepmc +1 more source
Quantification of Antibody-Drug Conjugate Targets in Head and Neck Squamous Cell Carcinoma. [PDF]
He M +11 more
europepmc +1 more source
Cationic nanoparticles with disrupting neutrophil extracellular traps inhibit the progression of head and neck squamous cell carcinoma. [PDF]
Zhang Z +5 more
europepmc +1 more source
SLC25A1 upregulation promotes HNSCC cisplatin resistance via H3K27ac-mediated cellular senescence. [PDF]
Li J +12 more
europepmc +1 more source
Biomarker-Stratified Efficacy of Immune Checkpoint Inhibitors in Locally Advanced Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis of Randomized Trials. [PDF]
Srinivasmurthy R +11 more
europepmc +1 more source
Genomic Enrichment and Functional Impact of TP53 and CYLD Alterations in Recurrent and Metastatic HPV-Associated Head and Neck Cancer. [PDF]
Prasad M +26 more
europepmc +1 more source

